(American Society for Biochemistry and Molecular Biology) A key protein potentially involved in regulating breast cancer progression has been identified by researchers at Clarkson University in Potsdam, N.Y. Led by professor Costel Darie, the team worked to identify the binding partner of Tumor Differentiating Factor, a pituitary hormone that had previously been shown to reduce cancer progression in breast cancer cells.

(American Society for Biochemistry and Molecular Biology) A key protein potentially involved in regulating breast cancer progression has been identified by researchers at Clarkson University in Potsdam, N.Y. Led by professor Costel Darie, the team worked to identify the binding partner of Tumor Differentiating Factor, a pituitary hormone that had previously been shown to reduce cancer progression in breast cancer cells.

(NYU Langone Medical Center / New York University School of Medicine) A new study published in the journal Nature Medicine by NYU Cancer Institute researchers, shows how the cancer causing gene Notch, in combination with a mutated Polycomb Repressive Complex 2 protein complex, work together to cause T- cell acute lymphoblastic leukemia.

(American Society for Biochemistry and Molecular Biology) A key protein potentially involved in regulating breast cancer progression has been identified by researchers at Clarkson University in Potsdam, N.Y. Led by professor Costel Darie, the team worked to identify the binding partner of Tumor Differentiating Factor, a pituitary hormone that had previously been shown to reduce cancer progression in breast cancer cells.

(University of Missouri-Columbia) University of Missouri researchers have now used advanced 3-D microscopic imaging technology to identify and monitor the proteins involved in the artery stiffening process. These findings could eventually help researchers and physicians understand and treat complications associated with cardiovascular disease.

(University of Missouri-Columbia) University of Missouri researchers have now used advanced 3-D microscopic imaging technology to identify and monitor the proteins involved in the artery stiffening process. These findings could eventually help researchers and physicians understand and treat complications associated with cardiovascular disease.

(Washington University in St. Louis) A biology lab at Washington University in St. Louis has successfully cracked the structure of an enzyme made by Plasmodium falciparum, the parasitical protozoan that causes the most lethal form of malaria. Plasmodium cannot live without the enzyme, which is uses to make cell membrane. Because people don’t make this enzyme, it is an ideal target for an anti-malarial drug. Such a drug might kill Plasmodium but have minimal side effects for people.

(Baylor College of Medicine) The anxiety and behavioral issues associated with excess MeCP2 protein result from overexpression of two genes (Crh [corticotropin-releasing hormone] and Oprm 1 [mu-opioid receptor MOR 1]), which may point the way to treating these problems in patients with too much of the protein, said Baylor College of Medicine scientists.

(Baylor College of Medicine) The anxiety and behavioral issues associated with excess MeCP2 protein result from overexpression of two genes (Crh [corticotropin-releasing hormone] and Oprm 1 [mu-opioid receptor MOR 1]), which may point the way to treating these problems in patients with too much of the protein, said Baylor College of Medicine scientists.

(Georgia Health Sciences University) Scientists have found at least one instance when the smaller sibling gets to call the shots and cancer patients may one day benefit.